Location History:
- Minnetonka, MN (US) (2006 - 2011)
- Burlingame, CA (US) (2012 - 2018)
Company Filing History:
4 out of 2,318 
3 out of 154 
2 out of 3,232 
Years Active: 2006-2018
Title: Innovations by Timothy W. Behrens
Introduction
Timothy W. Behrens is a notable inventor based in Burlingame, California. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of autoimmune diseases such as lupus. With a total of six patents to his name, Behrens has developed innovative methods that enhance patient care and treatment outcomes.
Latest Patents
Among his latest patents, Behrens has focused on methods for treating, diagnosing, and monitoring lupus. His work includes identifying and prognosing various subphenotypes of lupus, utilizing a set of alleles associated with systemic lupus erythematosus (SLE) risk loci. These loci include BLK, TNIP1, PRDM1, JAZF1, UHRF1BP1, IL10, IFIH1, CFB, CEC16A, IL12B, and SH2B3, which contribute to SLE risk. Additionally, he has developed methods for identifying effective lupus therapeutic agents and predicting patient responsiveness to these agents. Another significant patent involves biological markers that predict patient responsiveness to B-cell antagonists, along with methods for treating patients suffering from autoimmune diseases like rheumatoid arthritis.
Career Highlights
Behrens has had a distinguished career, working at prominent institutions such as the University of Minnesota and the Feinstein Institute for Medical Research. His research has been pivotal in advancing the understanding of autoimmune diseases and improving therapeutic strategies.
Collaborations
Throughout his career, Behrens has collaborated with esteemed colleagues, including Peter Gregersen and Emily C. Baechler. These collaborations have further enriched his research and contributed to the development of innovative solutions in the medical field.
Conclusion
Timothy W. Behrens is a prominent inventor whose work has significantly impacted the diagnosis and treatment of autoimmune diseases. His innovative patents and collaborations continue to advance medical research and improve patient outcomes.